Company profile
CytoSeek
Enabling the next generation of cell therapies for solid tumours through Artificial Membrane-Binding Proteins. CytoSeek is a preclinical biotech company based in Bristol, UK.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
CytoSeek develops cell membrane augmentation technology, with applications in cell therapies for various disorders.
Next generation cell therapies CytoSeek is developing its Artificial Membrane Binding Protein (AMBP) technology to enhance cell therapies for use in tumour therapies. AMBPs, which bind to virtually all cell types, have a modular design that allows rapid prototyping to deliver new functionalities. Currently, we are developing AMBPs that can provide homing, immunomodulation, and/or hypoxia resistance functionality.
Hone Bio develops cell membrane augmentation technology, with applications in cell therapies for various disorders.
None yet
Not yet evaluated.
1 May 2024 to 31 Oct 2025
This project, inspired by the success of lipid nanoparticle (LNP) based COVID-19 vaccines that reached \>1B people worldwide, aims to harness CytoSeek's state-of-the-art Artificial Membrane-Binding Protein (AMBP) technology for the precise targeting of LNPs to specific cell populations. This innovative approach holds potential for delivering advanced canc...
1 Jun 2020 to 30 Nov 2020
no public description
1 Oct 2019 to 30 Sep 2022
In 2018, more than 9.5 million people worldwide died from cancer, with more than 18 million new cancer incidences reported. A new approach using human immune cells to attack tumours is showing promise in the clinic. Within this exciting new field, CAR-T therapy has been shown to be effective against blood-based cancers, such as acute lymphoblastic leukaem...
1 Jan 2018 to 30 Sep 2019
During a heart attack, muscles in the heart suffer damage because of the loss of oxygen. Unfortunately, it is very difficult for the body to repair this damage, which weakens the heart and increases the chance of subsequent heart failure. An exciting new approach to repair this damage involves injecting stem cells into the surrounding areas to help repair...
